U.S. markets open in 3 hours 13 minutes
  • S&P Futures

    3,829.00
    +1.00 (+0.03%)
     
  • Dow Futures

    31,324.00
    -47.00 (-0.15%)
     
  • Nasdaq Futures

    12,810.00
    -21.75 (-0.17%)
     
  • Russell 2000 Futures

    2,193.40
    -6.60 (-0.30%)
     
  • Crude Oil

    63.06
    -0.47 (-0.74%)
     
  • Gold

    1,760.90
    -14.50 (-0.82%)
     
  • Silver

    26.91
    -0.77 (-2.80%)
     
  • EUR/USD

    1.2117
    -0.0069 (-0.57%)
     
  • 10-Yr Bond

    1.5180
    0.0000 (0.00%)
     
  • Vix

    28.73
    +7.39 (+34.63%)
     
  • GBP/USD

    1.3917
    -0.0096 (-0.69%)
     
  • USD/JPY

    106.3900
    +0.1600 (+0.15%)
     
  • BTC-USD

    46,468.61
    -2,897.43 (-5.87%)
     
  • CMC Crypto 200

    931.60
    -1.54 (-0.16%)
     
  • FTSE 100

    6,608.98
    -42.98 (-0.65%)
     
  • Nikkei 225

    28,966.01
    -1,202.26 (-3.99%)
     

What Kind Of Shareholders Own Amgen Inc. (NASDAQ:AMGN)?

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Simply Wall St
·4 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Every investor in Amgen Inc. (NASDAQ:AMGN) should be aware of the most powerful shareholder groups. Large companies usually have institutions as shareholders, and we usually see insiders owning shares in smaller companies. We also tend to see lower insider ownership in companies that were previously publicly owned.

Amgen has a market capitalization of US$138b, so it's too big to fly under the radar. We'd expect to see both institutions and retail investors owning a portion of the company. In the chart below, we can see that institutions own shares in the company. Let's take a closer look to see what the different types of shareholders can tell us about Amgen.

View our latest analysis for Amgen

ownership-breakdown
ownership-breakdown

What Does The Institutional Ownership Tell Us About Amgen?

Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.

Amgen already has institutions on the share registry. Indeed, they own a respectable stake in the company. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at Amgen's earnings history below. Of course, the future is what really matters.

earnings-and-revenue-growth
earnings-and-revenue-growth

Since institutional investors own more than half the issued stock, the board will likely have to pay attention to their preferences. We note that hedge funds don't have a meaningful investment in Amgen. Looking at our data, we can see that the largest shareholder is BlackRock, Inc. with 8.2% of shares outstanding. With 8.2% and 6.3% of the shares outstanding respectively, The Vanguard Group, Inc. and Capital Research and Management Company are the second and third largest shareholders.

After doing some more digging, we found that the top 25 have the combined ownership of 50% in the company, suggesting that no single shareholder has significant control over the company.

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. Quite a few analysts cover the stock, so you could look into forecast growth quite easily.

Insider Ownership Of Amgen

The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.

Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.

Our most recent data indicates that insiders own less than 1% of Amgen Inc.. As it is a large company, we'd only expect insiders to own a small percentage of it. But it's worth noting that they own US$189m worth of shares. In this sort of situation, it can be more interesting to see if those insiders have been buying or selling.

General Public Ownership

The general public, with a 22% stake in the company, will not easily be ignored. While this group can't necessarily call the shots, it can certainly have a real influence on how the company is run.

Next Steps:

While it is well worth considering the different groups that own a company, there are other factors that are even more important. Take risks for example - Amgen has 2 warning signs we think you should be aware of.

But ultimately it is the future, not the past, that will determine how well the owners of this business will do. Therefore we think it advisable to take a look at this free report showing whether analysts are predicting a brighter future.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.